首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cardiovascular Therapeutics

Cardiovascular Therapeutics杂志,由Wiley-Blackwell Publishing Ltd出版,于2008年创刊,Quarterly,出版语言English,ISSN:1755-5914,E-ISSN:1755-5922。

投稿咨询
Cardiovascular Therapeutics
Cardiovascular Therapeutics
Cardiovascular Therapeutics
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
2.8
CiteScore
6.1
期刊收录
SCI、SCIE

Cardiovascular Therapeutics(中文译名:《心血管治疗》),ISSN:1755-5914,EISSN:1755-5922,是Wiley-Blackwell Publishing Ltd出版的国际性学术期刊,创刊于2008年,以Quarterly形式稳定发行,2026年总发文量约64篇。该刊采用OA开放访问,学科归属为医学 - 心血管系统。该刊是医学、心脏和心血管系统领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.8,2025年期刊CiteScore为6.1,2025年期刊自引率约3.6%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Cardiovascular Therapeutics长期聚焦医学、心脏和心血管系统及相关产业的技术应用前沿,平均审稿周期约6月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、心脏和心血管系统领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Italy、South Korea、Poland、England、Singapore等为核心发文国家与地区;CAPITAL MEDICAL UNIVERSITYCHINESE ACADEMY OF MEDICAL SCIENCES - PEKING UNION MEDICAL COLLEGE、TIANJIN MEDICAL UNIVERSITY、SAPIENZA UNIVERSITY ROME、UNIVERSITY OF PADUA、CATHOLIC UNIVERSITY OF KOREA、CENTRAL SOUTH UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学
3区 3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学
3区 3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学 CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区 4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 101 / 237

57.6

学科:PHARMACOLOGY & PHARMACY SCIE Q3 181 / 356

49.3

学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 76 / 237

68.14

学科:PHARMACOLOGY & PHARMACY SCIE Q2 120 / 356

66.43

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 62 / 231

73.4

学科:PHARMACOLOGY & PHARMACY SCIE Q2 113 / 352

68

学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 67 / 231

71.21

学科:PHARMACOLOGY & PHARMACY SCIE Q2 107 / 353

69.83


中国学者近期发文

1
IL6/IL10/TLR4 Govern Immunogenic Cell Death in Aortic Dissectio

Author:Du, Yukui; Chang, Dongqing; Yu, Bofeng; Zhang, Li; He, Liang; Wang, Fengxia; Chang, Shaoyan

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/4140685

2
Effect of Statin Use on Mortality in Individuals With Cardiovascular-Kidney-Metabolic Syndrome: A Retrospective Propensity Score-Matched Cohort Stud

Author:Yuan, Cheng; Ge, Yuguo; Ge, Wenqi; Wang, Huaxue; Deng, Ximing; Chen, Jinmeng; Niu, Kaixuan; Xiong, Jinhui; Xu, Yang; Lu, Kun

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/7480081

3
The Association Between Sedentary Behavior and Cardiovascular Disease Risk: An Analysis Based on NHANES Dat

Author:Huang, Heming; Zhao, Zhe; Yu, Zemou; Feng, Fan; Zhang, Zaifeng; Fan, Bingge; Meng, Ling-bing

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/6940329

4
Association of Initial Laxative Strategy With Clinical Outcomes in Critically Ill Patients With Acute Myocardial Infarction: A Retrospective Cohort Stud

Author:Wang, Bingfu; Song, Yulong; Fan, Yujian; Zhao, Zhiqiang

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/1649836

5
Integrating Traditional Wisdom With Modern Science: Ginsenosides as Antiheart Failure Agent

Author:Zhou, Li; Li, Yanhua; Yin, Wenjie; Gu, Xi; Shi, Jiana; Yang, Fan

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/3078311

6
The Combined Double-Orifice and Single-Patch Technique for Partial Atrioventricular Septal Defect in Adults: A Novel Strateg

Author:Zheng, Hua-Jie; Xiao, Rui-Han; Ye, Mao-Ting; Li, Jun; Guo, Mei; Yu, San-Jiu; Cheng, Yong-Bo; Cheng, Wei

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/8493694

7
Postoperative Atrial Fibrillation Impacted by Completeness of Coronary Revascularization and Antiplatelet Regime

Author:Jiang, Qin; Xie, Minghui; Yu, Yalu; Tang, Zhiai; Xia, Jiaqi; Hu, Shengshou

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/8857148

8
The Impact of the Metal Mixture Inflammation Index on All-Cause Mortality in Patients With Cardiovascular-Kidney-Metabolic Syndrome Stages 0-3: A Study Based on NHANES 1999-201

Author:Ding, Wenlong; Shi, Fachao; Fang, Lei; Cui, Qin; Fang, Caoyang

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/1178167

9
Interpretable Machine Learning Model for Predicting 30-Day Readmission in Advanced Heart Failure Patients: Synergistic Assessment of Inflammatory and Metabolic Biomarker

Author:Zang, Baohe; Li, Chengyu; Zhou, Min; Chao, Yali

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/2307901

10
Asprosin Protects H9C2 Cells From Ferroptosis Following Hypoxia/Reoxygenation by Promoting Mitophag

Author:Wang, Xiangkun; Zhang, Xiaoyu; Tang, Huaiguang; Su, Xiaojuan; Ding, Shutong; Li, Xuelian; Li, Bingong

Journal: CARDIOVASCULAR THERAPEUTICS. 2026; Vol. 2026, Issue 1, pp. -. DOI: 10.1155/cdr/8401037


在线咨询

Cardiovascular Therapeutics

国际简称:CARDIOVASC THER参考译名:心血管治疗

年发文量:64 CiteScore:6.1 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:84.38%

杂志社联系方式:WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Cardiovascular Therapeutics